These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1228 related items for PubMed ID: 15226336

  • 1. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882.
    J Clin Oncol; 2004 Jul 01; 22(13):2691-700. PubMed ID: 15226336
    [Abstract] [Full Text] [Related]

  • 2. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B, Pediatric Oncology Group 9048, Children's Cancer Group 8891.
    J Clin Oncol; 2004 Sep 01; 22(17):3563-9. PubMed ID: 15337806
    [Abstract] [Full Text] [Related]

  • 3. Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.
    Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA, Children's Oncology Group.
    Cancer; 2005 Aug 15; 104(4):841-7. PubMed ID: 15999362
    [Abstract] [Full Text] [Related]

  • 4. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).
    Rescorla F, Billmire D, Stolar C, Vinocur C, Colombani P, Cullen J, Giller R, Cushing B, Lauer S, Davis M, Hawkins E, Shuster J, Krailo M.
    J Pediatr Surg; 2001 Jan 15; 36(1):12-7. PubMed ID: 11150431
    [Abstract] [Full Text] [Related]

  • 5. Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study.
    Billmire D, Vinocur C, Rescorla F, Colombani P, Cushing B, Hawkins E, Davis M, London WB, Lauer S, Giller R, Children's Oncology Group.
    J Pediatr Surg; 2003 Mar 15; 38(3):315-8; discussion 315-8. PubMed ID: 12632341
    [Abstract] [Full Text] [Related]

  • 6. Malignant mediastinal germ cell tumors: an intergroup study.
    Billmire D, Vinocur C, Rescorla F, Colombani P, Cushing B, Hawkins E, London WB, Giller R, Lauer S.
    J Pediatr Surg; 2001 Jan 15; 36(1):18-24. PubMed ID: 11150432
    [Abstract] [Full Text] [Related]

  • 7. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U.
    Klin Padiatr; 1993 Jan 15; 205(4):231-40. PubMed ID: 7690864
    [Abstract] [Full Text] [Related]

  • 8. Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
    Grimison PS, Stockler MR, Thomson DB, Olver IN, Harvey VJ, Gebski VJ, Lewis CR, Levi JA, Boyer MJ, Gurney H, Craft P, Boland AL, Simes RJ, Toner GC.
    J Natl Cancer Inst; 2010 Aug 18; 102(16):1253-62. PubMed ID: 20631341
    [Abstract] [Full Text] [Related]

  • 9. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec 18; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 10. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S, Kramar A, Théodore C, Geoffrois L, Chevreau C, Biron P, Nguyen BB, Héron JF, Kerbrat P, Caty A, Delva R, Fargeot P, Fizazi K, Bouzy J, Droz JP, Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    J Clin Oncol; 2008 Jan 20; 26(3):421-7. PubMed ID: 18202419
    [Abstract] [Full Text] [Related]

  • 11. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 12. Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.
    Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Villaluna D, Krailo M, Billmire DF, Rescorla FJ, Egler RA, Dicken BJ, Ross JH, Schlatter M, Rodriguez-Galindo C, Frazier AL.
    J Clin Oncol; 2017 Apr 10; 35(11):1203-1210. PubMed ID: 28240974
    [Abstract] [Full Text] [Related]

  • 13. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S, Venner PM, North SA.
    Can J Urol; 2007 Oct 10; 14(5):3692-6. PubMed ID: 17949524
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U, Bamberg M, Engert J, Gnekow AK, Haas HJ, Jürgens H, Kühl J, Lenard HG, Lumenta C, Niethammer D.
    Klin Padiatr; 1991 Oct 10; 203(4):236-45. PubMed ID: 1719267
    [Abstract] [Full Text] [Related]

  • 15. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Oct 10; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 16. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    J Urol; 2008 Jan 10; 179(1):163-6. PubMed ID: 18001800
    [Abstract] [Full Text] [Related]

  • 17. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group.
    J Clin Oncol; 2008 Jun 20; 26(18):2966-72. PubMed ID: 18458040
    [Abstract] [Full Text] [Related]

  • 18. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
    Brada M, Horwich A, Peckham MJ.
    Cancer Treat Rep; 1987 Jun 20; 71(6):655-6. PubMed ID: 2438041
    [Abstract] [Full Text] [Related]

  • 19. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors.
    Stern JW, Bunin N.
    Med Pediatr Oncol; 2002 Sep 20; 39(3):163-7. PubMed ID: 12210444
    [Abstract] [Full Text] [Related]

  • 20. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT.
    Obstet Gynecol; 1996 Apr 20; 87(4):527-31. PubMed ID: 8602303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.